IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity-Reference-Cited by-同舟云学术

IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity

Published:2024-01 Issue:1 Volume:153 Page:193-202
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Chongpison Yuda^ORCID,Sriswasdi Sira,Buranapraditkun Supranee,Thantiworasit Pattarawat,Rerknimitr Pawinee,Mongkolpathumrat Pungjai,Chularojanamontri Leena,Srinoulprasert Yuttana,Rerkpattanapipat Ticha,Chanprapaph Kumutnart,Disphanurat Wareeporn,Chakkavittumrong Panlop,Tovanabutra Napatra,Srisuttiyakorn Chutika,Sukasem Chonlaphat,Tuchinda Papapit,Pongcharoen Padcha,Klaewsongkram Jettanong^ORCID

Funder

Chulalongkorn University

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Epidemiology and risk factors for drug allergy;Thong;Br J Clin Pharmacol,2011

2. Recent developments and highlights in drug hypersensitivity;Mayorga;Allergy,2019

3. Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity;Bavbek;Qual Life Res,2016

4. Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study;Chongpison;Int J Qual Health Care,2018

5. Assessment of validity and reliability of Drug Hypersensitivity Quality of Life Questionnaire: the Dutch experience;Moayeri;Eur Ann Allergy Clin Immunol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions;World Allergy Organization Journal;2024-08

2. Predictive models and applicability of artificial intelligence-based approaches in drug allergy;Current Opinion in Allergy & Clinical Immunology;2024-05-30

3. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

4. Omeprazole Induced Rapid Drug Reaction with Eosinophilia, Systemic Symptoms, and Cross-Reactivity in Delayed-Type Hypersensitivity Associated with Proton-Pump Inhibitors: A Case Report and Literature Review;Case Reports in Immunology;2024-01-03